These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11430928)

  • 1. Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity.
    Bundkirchen A; Brixius K; Bölck B; Mehlhorn U; Bloch W; Schwinger RH
    Eur J Pharmacol; 2001 Jun; 422(1-3):175-80. PubMed ID: 11430928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
    Brixius K; Bundkirchen A; Bölck B; Mehlhorn U; Schwinger RH
    Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of beta-adrenoceptor antagonists on myofilament calcium sensitivity of rabbit and human myocardium.
    Zeitz O; Rahman A; Hasenfuss G; Janssen PM
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):126-31. PubMed ID: 10892670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with carvedilol improves Ca(2+)-dependent ATP consumption in triton X-skinned fiber preparations of human myocardium.
    Brixius K; Lu R; Boelck B; Grafweg S; Hoyer F; Pott C; Mehlhorn U; Bloch W; Schwinger RH
    J Pharmacol Exp Ther; 2007 Jul; 322(1):222-7. PubMed ID: 17409273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of inverse agonistic activity of nebivolol, its D- and L-enantiomers and of in vivo metabolized nebivolol in human myocardium.
    Bundkirchen A; Nguyen Q; Brixius K; Bölck B; Mehlhorn U; Schwinger RH
    Eur J Pharmacol; 2003 Aug; 476(1-2):97-105. PubMed ID: 12969754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium.
    Maack C; Tyroller S; Schnabel P; Cremers B; Dabew E; Südkamp M; Böhm M
    Br J Pharmacol; 2001 Apr; 132(8):1817-26. PubMed ID: 11309254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium.
    Maack C; Cremers B; Flesch M; Höper A; Südkamp M; Böhm M
    Br J Pharmacol; 2000 Jul; 130(5):1131-9. PubMed ID: 10882399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.
    Flesch M; Maack C; Cremers B; Bäumer AT; Südkamp M; Böhm M
    Circulation; 1999 Jul; 100(4):346-53. PubMed ID: 10421593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ENOS is not activated by nebivolol in human failing myocardium.
    Brixius K; Song Q; Malick A; Boelck B; Addicks K; Bloch W; Mehlhorn U; Schwinger RH
    Life Sci; 2006 Aug; 79(13):1234-41. PubMed ID: 16716362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
    Molenaar P; Christ T; Ravens U; Kaumann A
    Cardiovasc Res; 2006 Jan; 69(1):128-39. PubMed ID: 16225854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium.
    Brixius K; Savidou-Zaroti P; Bloch W; Schwinger RH
    Eur J Appl Physiol; 2003 May; 89(3-4):249-56. PubMed ID: 12736832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical scavenging and NO-releasing properties of selected beta-adrenoreceptor antagonists.
    Szajerski P; Zielonka J; Sikora A; Adamus J; Marcinek A; Gebicki J; Kozlovski VI; Drelicharz L; Chłopicki S
    Free Radic Res; 2006 Jul; 40(7):741-52. PubMed ID: 16984001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nebivolol on human platelet aggregation.
    Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-thrombotic effects of nebivolol and carvedilol: Involvement of β2 receptors and COX-2/PGI2 pathways.
    Kozlovski VI; Lomnicka M; Bartus M; Sternak M; Chlopicki S
    Pharmacol Rep; 2015 Oct; 67(5):1041-7. PubMed ID: 26398401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
    De Cree J; Van Nueten L; Geukens H; Verhaegen H
    Int J Clin Pharmacol Res; 1992; 12(4):159-63. PubMed ID: 1363660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Flesch M; Ettelbrück S; Rosenkranz S; Maack C; Cremers B; Schlüter KD; Zolk O; Böhm M
    Cardiovasc Res; 2001 Feb; 49(2):371-80. PubMed ID: 11164847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
    Zhao Q; Wu TG; Jiang ZF; Chen GW; Lin Y; Wang LX
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):85-90. PubMed ID: 17440824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.